Uses of hsa-mirna-423-5p and hsa-mirna-423-5p inhibitors
A technology of inhibitors and uses, applied in the field of biomedical engineering, can solve problems such as large side effects and severe liver and kidney damage in patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Serum hsa-miRNA-423-5p expression level in embodiment 1 pulmonary tuberculosis patients and healthy controls
[0020] 1 material
[0021] 1.1 Case samples
[0022] 1.1.1 Diagnostic criteria for pulmonary tuberculosis
[0023] The clinical diagnosis was based on the diagnostic criteria for pulmonary tuberculosis issued by the Ministry of Health of China and the revised International Tuberculosis Control Regulations.
[0024] All tuberculosis patients who met the following items were included in this embodiment: ① All cases were diagnosed as pulmonary tuberculosis according to the national diagnostic criteria for tuberculosis based on clinical manifestations, bacterial culture and imaging examination; ② HIV tests were negative, no history of tuberculosis, no Chronic obstructive pulmonary disease, asthma, pneumonia, lung cancer, diabetes, hypertension and other complications, normal liver and kidney function, no other congenital diseases, chronic inflammation, autoimmune...
Embodiment 2
[0075] Example 2 hsa-miRNA-423-5p blocks autophagosome maturation
[0076] The hsa-miRNA-423-5p mimic (hsa-miRNA-423-5p mimic for short), which is a nucleic acid fragment 5'-ugaggggcagagagcgagacuuu-3' synthesized in vitro, is stored in vacuum freeze-dried powder at -20°C. The hsa-miRNA-423-5p mimic powder was treated with RNase free ddH 2 O was dissolved at room temperature to 20uM, and stored in aliquots. The hsa-miRNA-423-5p solution was used to transfect human macrophage THP-1 in vitro at a concentration of 100 nM.
[0077] Laser confocal microscopy was used to detect the co-localization of autophagosomes and lysosomes. See the test results figure 2 . exist figure 2 In , compared with the control, the ratio of yellow dots / (yellow dots + green dots) is low, indicating that autophagy maturation is blocked, which is determined by figure 2 It can be seen that hsa-miRNA-423-5p mimic can lead to obvious autophagy maturation inhibition. Further, the expression level of a...
Embodiment 3
[0078] Example 3 hsa-miRNA-423-5p inhibitor relieves the phenomenon of autophagy maturation blockage
[0079] hsa-miRNA-423-5p inhibitor, which is an in vitro synthetic nucleic acid fragment 5'-aaagucutcgcucucugccccuca-3', hsa-miRNA-423-5p inhibitor powder with RNase free ddH 2 O was dissolved at room temperature to 20uM, and stored in aliquots. The hsa-miRNA-423-5p inhibitor solution was used to transfect human macrophage THP-1 in vitro at a concentration of 100 nM.
[0080] Laser confocal microscopy was used to detect the co-localization of autophagosomes and lysosomes. See the test results image 3 . exist image 3 Among them, compared with the hsa-miRNA-423-5p mimic treatment group, the ratio of yellow dots / (yellow dots + green dots) increased, indicating that the blockage of autophagy maturation was released. image 3 It can be seen that hsa-miRNA-423-5p inhibitor can lead to the relief of autophagy maturation blockage. Further, the expression level of a protein VPS...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com